Literature DB >> 16087901

Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data.

C C Price1, A L Jefferson, J G Merino, K M Heilman, D J Libon.   

Abstract

BACKGROUND: Research criteria for subcortical vascular dementia are based on radiologic evidence of vascular pathology and greater impairment on tests of executive control than memory. The relationship(s) between neuroradiological evidence of subcortical vascular disease and neuropsychological impairments has not been specified.
OBJECTIVE: To define these research criteria, the authors rated the severity of MRI white matter abnormalities (WMAs) and neuropsychological data from patients with dementia.
METHODS: Sixty-nine outpatients who met the criteria for dementia were studied with neuropsychological tests that assessed executive (mental) control, declarative memory, visuoconstruction (clock drawing), and language (semantic category fluency). MRI-WMAs were rated using a leukoaraiosis (LA) scale (range 0 to 40).
RESULTS: First, regression analyses demonstrated that neuropsychological measures accounted for 60.7% of the variance in WMA severity (47.3% of this variance attributable to executive/visuoconstructive test performance, 13.4% attributable to memory/language test performance). Second, patients were grouped according to the severity of WMAs (i.e., low, moderate, and severe white matter groups). Only patients with mild WMA (mean LA = 3.61 +/- 2.63, approximately 2.4 to 15.6% of the subcortical white matter) presented with greater impairment on memory/language tests vs executive control/visuoconstructive tests, a neuropsychological profile typically associated with Alzheimer disease. Patients with moderate WMA (mean LA = 12.76 +/- 2.49, approximately 25.6 to 38.1% of the subcortical white matter) presented with equal impairment on executive/visuoconstructional vs memory/language tests. Patients with severe WMA (mean LA = 21.76 +/- 2.97, approximately 46.9 to 62.4% of the subcortical white matter) displayed a profile of greater executive/visuoconstructional impairment relative to memory/language disabilities.
CONCLUSION: A profile of equal impairment on tests of executive control and memory along with radiologic evidence involving about one-fourth of the cerebral white matter as measured by the Leukoaraiosis Scale may be sufficient for a diagnosis of subcortical vascular dementia.

Entities:  

Mesh:

Year:  2005        PMID: 16087901      PMCID: PMC2746450          DOI: 10.1212/01.wnl.0000168877.06011.15

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  41 in total

1.  Generating 'tiger' as an animal name or a word beginning with T: differences in brain activation.

Authors:  C J Mummery; K Patterson; J R Hodges; R J Wise
Journal:  Proc Biol Sci       Date:  1996-08-22       Impact factor: 5.349

2.  The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm.

Authors:  Stephanie A Cosentino; Angela Lee Jefferson; Marissa Carey; Catherine C Price; Kelly Davis-Garrett; Rod Swenson; David J Libon
Journal:  Clin Neuropsychol       Date:  2004-02       Impact factor: 3.535

3.  Executive dysfunction in early Alzheimer's disease.

Authors:  G Binetti; E Magni; A Padovani; S F Cappa; A Bianchetti; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  A comparison of rCBF patterns during letter and semantic fluency.

Authors:  M L Gourovitch; B S Kirkby; T E Goldberg; D R Weinberger; J M Gold; G Esposito; J D Van Horn; K F Berman
Journal:  Neuropsychology       Date:  2000-07       Impact factor: 3.295

5.  Visuoconstructional problems in dementia: contribution of executive systems functions.

Authors:  R Q Freeman; T Giovannetti; M Lamar; B S Cloud; R A Stern; E Kaplan; D J Libon
Journal:  Neuropsychology       Date:  2000-07       Impact factor: 3.295

Review 6.  Executive control function: a rational basis for the diagnosis of vascular dementia.

Authors:  G C Román; D R Royall
Journal:  Alzheimer Dis Assoc Disord       Date:  1999 Oct-Dec       Impact factor: 2.703

7.  The ICD-10 criteria for vascular dementia.

Authors:  T Wetterling; R D Kanitz; K J Borgis
Journal:  Dementia       Date:  1994 May-Aug

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  Clock drawing errors in dementia: neuropsychological and neuroanatomical considerations.

Authors:  Stephanie Cosentino; Angela Jefferson; Douglas L Chute; Edith Kaplan; David J Libon
Journal:  Cogn Behav Neurol       Date:  2004-06       Impact factor: 1.600

10.  Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia.

Authors:  D J Libon; B Bogdanoff; B S Cloud; S Skalina; T Giovannetti; H L Gitlin; J Bonavita
Journal:  J Clin Exp Neuropsychol       Date:  1998-02       Impact factor: 2.475

View more
  32 in total

1.  Leukoaraiosis severity and list-learning in dementia.

Authors:  Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon
Journal:  Clin Neuropsychol       Date:  2009-08       Impact factor: 3.535

Review 2.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

3.  Clock drawing in the Montreal Cognitive Assessment: recommendations for dementia assessment.

Authors:  Catherine C Price; Holly Cunningham; Nicole Coronado; Alana Freedland; Stephanie Cosentino; Dana L Penney; Alfio Penisi; Dawn Bowers; Michael S Okun; David J Libon
Journal:  Dement Geriatr Cogn Disord       Date:  2011-03-10       Impact factor: 2.959

4.  Verbal serial list learning in mild cognitive impairment: a profile analysis of interference, forgetting, and errors.

Authors:  David J Libon; Mark W Bondi; Catherine C Price; Melissa Lamar; Joel Eppig; Denene M Wambach; Christine Nieves; Lisa Delano-Wood; Tania Giovannetti; Carol Lippa; Anahid Kabasakalian; Stephanie Cosentino; Rod Swenson; Dana L Penney
Journal:  J Int Neuropsychol Soc       Date:  2011-09       Impact factor: 2.892

5.  Normative data for a battery of free recall, cued recall and recognition tests in the elderly Italian population.

Authors:  Emanuele Coluccia; Nadia Gamboz; Maria A Brandimonte
Journal:  Neurol Sci       Date:  2011-09-15       Impact factor: 3.307

Review 6.  The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation.

Authors:  Marilyn J Cipolla; David S Liebeskind; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-10       Impact factor: 6.200

Review 7.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 8.  MRI-detected white matter lesions: do they really matter?

Authors:  Reinhold Schmidt; Anja Grazer; Christian Enzinger; Stefan Ropele; Nina Homayoon; Aga Pluta-Fuerst; Petra Schwingenschuh; Petra Katschnig; Margherita Cavalieri; Helena Schmidt; Christian Langkammer; Franz Ebner; Franz Fazekas
Journal:  J Neural Transm (Vienna)       Date:  2011-02-22       Impact factor: 3.575

Review 9.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

10.  MRI-leukoaraiosis thresholds and the phenotypic expression of dementia.

Authors:  Catherine C Price; Sandra M Mitchell; Babette Brumback; Jared J Tanner; Ilona Schmalfuss; Melissa Lamar; Tania Giovannetti; Kenneth M Heilman; David J Libon
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.